Hundreds sue Novo Nordisk, Eli Lilly over GLP-1 vision loss claims
Patients allege Ozempic, Wegovy and Zepbound caused a rare form of vision loss without adequate warning; the drugmakers vow to fight the suits.
What to know
- Hundreds of lawsuits allege Novo Nordisk's and Eli Lilly's GLP-1 drugs (Ozempic, Wegovy, Zepbound) caused a rare type of vision loss without adequate warning.
- Novo Nordisk says it is vigorously fighting the claims and calls them without merit; Eli Lilly says patient safety is its top priority.
- The number of suits has grown from dozens to hundreds within the coverage window, indicating a rapidly expanding litigation wave.
“patient safety”
Eli Lilly, Drugmaker · NBC News broadcast ↗ · Sep 20
Novo Nordisk Maker of Ozempic and WegovyEli Lilly Maker of ZepboundPlaintiffs Patients suing the drugmakers
How it unfolded 2 developments, newest first · click a bar or a number to jump videosposts
-
2
Novo Nordisk and Eli Lilly respond to the lawsuits
Novo Nordisk said it is 'vigorously' fighting the lawsuits and called them without merit, while Eli Lilly said patient safety remains its top priority, as NBC News reported the litigation had grown to hundreds of cases.
“vigorously" fighting the lawsuits, saying they are "without merit…”
— Novo Nordisk -
first by WSJ, 2d ago · also NewsNation, WSOC TV, Al Jazeera, The Hill, KTLA
5 more headlines
- GLP-1 makers Novo, Eli Lilly sued over sudden loss of vision in patients NewsNation · 2d ago
- Patients sue GLP-1 makers over risk of blindness WSOC TV · 2d ago
- Dozens of people sue GLP-1 drug companies over alleged vision loss Mastodon · 1d ago
- Woman Details Losing Vision After Taking GLP-1 for Weight-Loss As Patients Sue Drug Companies TODAY.com · 1d ago
- Patients sue GLP-1 makers over sudden loss of vision The Hill · 1d ago
-
Patients are suing GLP-1 drugmakers over the risk of sudden vision loss, per WSJ
2 more of the top 3 · 3 posts in this stretch
-
U
https://www. europesays.com/us/1079411/ Woman Details Losing Vision After Taking Wegovy As Patients Sue GLP-1 Drug Companies # Health # Medication # UnitedStates # UnitedStates # US
-
🇺🇸 The GLP-1 boom now comes with a frightening question: is losing weight worth it if comes with a risk to your eyesight? Dozens of lawsuits now allege Ozempic, Wegovy and Zepbound were linked to a rare form of vision loss, putting the companies behind some of the world’s most
-
-
1
Lawsuits filed against Novo Nordisk and Eli Lilly over vision loss
Dozens, later reported as hundreds, of lawsuits were filed against the makers of Ozempic, Wegovy and Zepbound, claiming the GLP-1 drugs led to a rare type of vision loss.
“Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss.”
— ABC News -
first by Boston Globe, 1d ago · also Fox News, The Boston Globe
1 more headline
-
first by WMUR, 1d ago · also AZ Family
1 more headline
-
Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss. ABC News' Elizabeth Schulze reports.
-
Also covered reported alongside — the timeline has no entry for these yet
-
first by USA Today, 2d ago · also ABC News - Breaking News, Latest News and Videos
1 more headline
- What GLP-1 users should know about the potential risk of a rare type of vision loss ABC News - Breaking News, Latest News and Videos · 2d ago
and 4 smaller pieces
